On-Demand Webinar

A review on treatment intensification and current barriers in patients with metastatic hormone sensitive prostate cancer (mHSPC)

Click on the Chapters icon in the video toolbar to navigate through the sections of the video

Date of original release: February 6 2023
Date credits expire: February 6 2024

These webinars have been supported by an educational grant from Astellas, Bayer and Janssen Biotech Inc. (administered by Janssen Scientific Affairs, LLC). The sponsors has had no influence over the content or selection of the Editorial Panel.

ACCREDITATIONS:

John Wiley & Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Wiley designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM per e-learning. Physicians should claim only the credit commensurate with the extent of their participation in the activity.